Betrixaban is prescribed for:
- VTE prophylaxis in acutely ill hospitalized patients
- Extended-duration thromboprophylaxis (35-42 days)
- Cardiovascular prevention
Unique indication among oral anticoagulants.
Generic Name: Betrixaban
Brand Names: Bevyxxa
Betrixaban is a factor Xa inhibitor specifically approved for VTE prevention in acutely ill hospitalized patients.
Betrixaban is prescribed for:
Unique indication among oral anticoagulants.
Common side effects:
Serious side effects:
Betrixaban is an oral factor Xa inhibitor with a unique indication for extended VTE prophylaxis in medical patients.
Approved for 35-42 days of prophylaxis - extending protection beyond hospitalization.
Not approved for atrial fibrillation or VTE treatment - only prophylaxis in medical patients.
For details, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Atrial fibrillation, a common arrhythmia characterized by rapid, irregular heartbeats, increases risk of stroke and heart failure, often linked to age, hypertension, and heart disease.
Osteoarthritis, a common degenerative joint disease, causes pain, stiffness, and reduced motion due to cartilage breakdown from aging, genetics, obesity, injuries, or repetitive stress.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Betrixaban? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.